Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | 1 | 3 | 4 | 9 | 17 |
Thrombosis | D013927 | — | — | 2 | 2 | 3 | 2 | — | 9 |
Thromboembolism | D013923 | — | — | 2 | — | — | 2 | 4 | 8 |
Embolism | D004617 | — | — | — | — | 3 | 1 | 2 | 6 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | 1 | — | — | 1 | 4 | 6 |
Venous thrombosis | D020246 | — | I82.40 | — | 1 | 3 | 1 | — | 5 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | 1 | 1 | 3 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | 1 | 1 | 1 | — | 3 |
Syndrome | D013577 | — | — | — | 1 | 1 | 1 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | 3 | — | — | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 1 | — | — | 2 |
Cerebral infarction | D002544 | — | I63 | — | — | 1 | — | — | 1 |
Ischemic stroke | D000083242 | — | — | — | — | 1 | — | — | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | 1 | — | — | 1 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | 1 | — | — | 1 |
Leukemia | D007938 | — | C95 | — | — | 1 | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | — | — | 1 | — | — | 1 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | — | 1 | — | — | 1 |
Lymphoid leukemia | D007945 | — | C91 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | — | 1 |
Pneumonia | D011014 | EFO_0003106 | J18 | — | 1 | — | — | — | 1 |
Inflammation | D007249 | MP_0001845 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 9 | — | — | — | — | 9 |
Crush injuries | D000071576 | — | T14.8 | 1 | — | — | — | — | 1 |
Overweight | D050177 | — | E66.3 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 1 | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
Neoplasms | D009369 | — | C80 | — | — | — | — | 1 | 1 |
Osteoporosis | D010024 | EFO_0003882 | M81.0 | — | — | — | — | 1 | 1 |
Drug common name | Serine |
INN | dexfosfoserine |
Description | L-serine is the L-enantiomer of serine. It has a role as a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a serine family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and a serine. It is a conjugate base of a L-serinium. It is a conjugate acid of a L-serinate. It is an enantiomer of a D-serine. It is a tautomer of a L-serine zwitterion. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N[C@@H](CO)C(=O)O |
PDB | — |
CAS-ID | 56-45-1 |
RxCUI | — |
ChEMBL ID | CHEMBL11298 |
ChEBI ID | 17115 |
PubChem CID | 5951 |
DrugBank | DB00133 |
UNII ID | VI4F0K069V (ChemIDplus, GSRS) |